China Reins In Cancer Drug Trials, Stressing Patient Needs and Benefits

Tougher Comparator Requirements

clinical trial progress
China’s CDE stipulates clinical value is determined by whether clinical needs can be met to maximize patients’ benefits • Source: Alamy

More from China

More from Focus On Asia